Nektar Therapeutics (Nasdaq:NKTR) will announce its financial results for the first quarter 2007 on Wednesday, May 9, 2007, after the close of United States-based financial markets. On that day, Howard Robin, president and chief executive officer, will host a conference call for analysts and investors beginning at 4:30 p.m. Eastern Time (ET).
Investors can access the press release and a live audio-only Webcast of the conference call through a link that is posted on the Investor Relations section of the Nektar website: http://www.nektar.com. The web broadcast of the conference call will be available for replay through May 23, 2007.
To access the conference call, follow these instructions:
Dial: (800) 640-9765 (U.S.); (847) 413-4837 (international). Passcode: 17659665 (Howard Robin is the host).
An audio replay will be available shortly following the call through May 23, 2007 and can be accessed by dialing (877) 213-9653 (U.S.); or (630) 652-3041 (international) with a passcode of 17659665. In the event that any non-GAAP financial measure is discussed on the conference call that is not described in the press release, related information will be made available on the Investor Relations page at the Nektar website as soon as practical after the conclusion of the conference call.
Nektar Therapeutics applies its industry leading pulmonary and PEGylation technology platforms to improve the safety, efficacy and compliance of medicines already available to develop novel therapeutics.
